Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 5Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Observational 4Interventional 1

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 5Neoplasms 3Uterine Neoplasms 1Stomach Neoplasms 1Obesity 1Motor Activity 1Colorectal Neoplasms 1Cholangiocarcinoma 1Cardiotoxicity 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Biomarkers × Clear all
NCT02605512 2023-11-08

BACCARAT

Institut de Radioprotection et de Surete Nucleaire

Phase NA Completed
118 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT03148015 2022-05-27

Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)

Sentara Norfolk General Hospital

Completed
30 enrolled
Breast

Breast Neoplasms

NCT02496260 2022-03-03

Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy

Henry Ford Health System

Completed
25 enrolled
Breast

Breast Neoplasms

NCT02494453 2019-07-30

Pilot Study of Biomarkers and Cardiac MRI as Early Indicators of Cardiac Exposure Following Breast Radiotherapy

University of Michigan Rogel Cancer Center

Completed
23 enrolled
Breast

Breast Neoplasms

NCT00539422 2007-10-04

Role of Cytochrome P450 2D6 (CYP2D6) *4 Polymorphism,in Malignant Breast Diseases

Mansoura University

Completed
Breast

Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡